Cochlear | COH - Ebitda


Cochlear reported AUD306.4M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Ansell USD 185.8M 7M Dec/2025
Avita Medical AUD -5.56M 4.13M Jun/2026
Cochlear AUD 306.4M 13.5M Dec/2025
CSL USD 3.13B 1.17B Dec/2025
Fisher Paykel Healthcare NZD 434M 70M Jun/2026
Healius AUD 74.9M 40.3M Jun/2025
Integral Diagnostics AUD 46.27M 3.52M Jun/2024
Mayne Pharma AUD 20.9M 5.2M Jun/2025
Mesoblast USD -17.08M 3.21M Jun/2026
Monash IVF AUD 30.16M 583K Dec/2025
Nanosonics AUD 12.49M 1.13M Dec/2025
Polynovo AUD 3.89M 100K Dec/2025
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
Regis Healthcare AUD 70.59M 12.81M Dec/2025
ResMed USD 533.74M 29.91M Sep/2026
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Somnomed AUD 764.45K 479.23K Jun/2023
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Telix Pharmaceuticals AUD 76.49M 58.07M Jun/2026